Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Vessel Anomalies | 20 | 2025 | 269 | 6.530 |
Why?
|
| Coronary Artery Disease | 6 | 2023 | 741 | 2.150 |
Why?
|
| Myocardial Ischemia | 4 | 2023 | 330 | 1.990 |
Why?
|
| Fractional Flow Reserve, Myocardial | 4 | 2025 | 35 | 1.800 |
Why?
|
| Mitral Valve Prolapse | 3 | 2024 | 28 | 1.360 |
Why?
|
| Marfan Syndrome | 3 | 2024 | 136 | 1.220 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2024 | 154 | 1.190 |
Why?
|
| Death, Sudden, Cardiac | 5 | 2024 | 244 | 1.030 |
Why?
|
| Coronary Vessels | 8 | 2023 | 525 | 0.990 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2024 | 365 | 0.990 |
Why?
|
| Aorta | 12 | 2025 | 534 | 0.960 |
Why?
|
| Ventricular Function, Left | 5 | 2024 | 500 | 0.910 |
Why?
|
| Myocardial Bridging | 1 | 2024 | 12 | 0.910 |
Why?
|
| Pulmonary Atresia | 1 | 2024 | 48 | 0.890 |
Why?
|
| Child | 26 | 2025 | 24064 | 0.820 |
Why?
|
| Echocardiography | 6 | 2024 | 1066 | 0.820 |
Why?
|
| Endocarditis | 1 | 2023 | 103 | 0.800 |
Why?
|
| Endocarditis, Bacterial | 1 | 2023 | 129 | 0.800 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 234 | 0.800 |
Why?
|
| Severe Dengue | 1 | 2021 | 8 | 0.780 |
Why?
|
| Hydrocortisone | 1 | 2021 | 215 | 0.730 |
Why?
|
| Coronary Sinus | 1 | 2021 | 15 | 0.730 |
Why?
|
| Coronary Angiography | 5 | 2024 | 417 | 0.720 |
Why?
|
| Shock | 1 | 2021 | 89 | 0.710 |
Why?
|
| Magnetic Resonance Imaging, Cine | 5 | 2024 | 146 | 0.700 |
Why?
|
| Heart Septal Defects | 1 | 2020 | 40 | 0.690 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2024 | 1099 | 0.670 |
Why?
|
| Vascular Ring | 1 | 2019 | 6 | 0.670 |
Why?
|
| Coronary Stenosis | 1 | 2020 | 70 | 0.660 |
Why?
|
| Vascular Surgical Procedures | 3 | 2024 | 561 | 0.660 |
Why?
|
| Sports | 1 | 2019 | 59 | 0.650 |
Why?
|
| Adolescent | 18 | 2024 | 18940 | 0.640 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 138 | 0.640 |
Why?
|
| Chest Pain | 1 | 2019 | 125 | 0.630 |
Why?
|
| Heart Arrest | 1 | 2023 | 341 | 0.630 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 73 | 0.610 |
Why?
|
| Disease Progression | 1 | 2024 | 1991 | 0.610 |
Why?
|
| Mitral Valve | 3 | 2024 | 245 | 0.610 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 197 | 0.590 |
Why?
|
| Stents | 1 | 2024 | 864 | 0.580 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2019 | 142 | 0.570 |
Why?
|
| Exercise Test | 4 | 2024 | 247 | 0.570 |
Why?
|
| Myocardial Perfusion Imaging | 3 | 2024 | 57 | 0.550 |
Why?
|
| Humans | 45 | 2025 | 122296 | 0.550 |
Why?
|
| Computed Tomography Angiography | 3 | 2024 | 195 | 0.550 |
Why?
|
| Male | 25 | 2025 | 59522 | 0.510 |
Why?
|
| Abnormalities, Multiple | 2 | 2024 | 962 | 0.490 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 580 | 0.490 |
Why?
|
| Retrospective Studies | 15 | 2024 | 15853 | 0.440 |
Why?
|
| Cardiac Catheterization | 3 | 2024 | 631 | 0.430 |
Why?
|
| Heart Ventricles | 4 | 2024 | 767 | 0.380 |
Why?
|
| Child, Preschool | 9 | 2024 | 13777 | 0.380 |
Why?
|
| Female | 22 | 2024 | 64883 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3448 | 0.360 |
Why?
|
| Predictive Value of Tests | 5 | 2023 | 2080 | 0.360 |
Why?
|
| Treatment Outcome | 8 | 2024 | 12045 | 0.350 |
Why?
|
| Stroke Volume | 4 | 2024 | 446 | 0.340 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2024 | 251 | 0.340 |
Why?
|
| Pregnancy Complications | 2 | 2023 | 503 | 0.310 |
Why?
|
| Prospective Studies | 4 | 2024 | 5963 | 0.300 |
Why?
|
| Young Adult | 4 | 2023 | 8760 | 0.240 |
Why?
|
| Infant | 6 | 2024 | 12302 | 0.240 |
Why?
|
| Smad3 Protein | 1 | 2024 | 55 | 0.240 |
Why?
|
| Ventricular Function, Right | 2 | 2022 | 111 | 0.230 |
Why?
|
| Cor Triatriatum | 1 | 2024 | 11 | 0.230 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 3301 | 0.230 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2024 | 58 | 0.220 |
Why?
|
| Heart Defects, Congenital | 4 | 2024 | 1799 | 0.220 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8096 | 0.220 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 38 | 0.220 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2023 | 37 | 0.210 |
Why?
|
| Ischemia | 2 | 2023 | 342 | 0.210 |
Why?
|
| Hemodynamics | 2 | 2025 | 839 | 0.210 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 43 | 0.210 |
Why?
|
| Pulmonary Valve | 1 | 2024 | 98 | 0.210 |
Why?
|
| Aortic Coarctation | 1 | 2024 | 105 | 0.210 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2024 | 241 | 0.210 |
Why?
|
| Aorta, Thoracic | 2 | 2024 | 517 | 0.210 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 475 | 0.200 |
Why?
|
| Exercise | 2 | 2024 | 790 | 0.190 |
Why?
|
| Shock, Cardiogenic | 1 | 2023 | 189 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 168 | 0.190 |
Why?
|
| Dobutamine | 1 | 2021 | 56 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2024 | 749 | 0.190 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 1283 | 0.180 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 440 | 0.180 |
Why?
|
| Interleukin-10 | 1 | 2021 | 170 | 0.180 |
Why?
|
| Defibrillators | 1 | 2019 | 21 | 0.170 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2019 | 15 | 0.170 |
Why?
|
| Interleukin-6 | 1 | 2021 | 394 | 0.170 |
Why?
|
| Adult | 7 | 2024 | 28733 | 0.160 |
Why?
|
| Purines | 1 | 2019 | 107 | 0.160 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2019 | 113 | 0.160 |
Why?
|
| Infant, Premature | 1 | 2024 | 799 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2024 | 4643 | 0.150 |
Why?
|
| Parents | 1 | 2024 | 1016 | 0.140 |
Why?
|
| Aortic Valve | 1 | 2020 | 426 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2019 | 300 | 0.140 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 486 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 479 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2021 | 963 | 0.120 |
Why?
|
| Gestational Age | 1 | 2019 | 1115 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2020 | 1158 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2030 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2021 | 841 | 0.120 |
Why?
|
| Age Factors | 1 | 2020 | 2777 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 994 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2817 | 0.100 |
Why?
|
| Texas | 1 | 2020 | 3528 | 0.100 |
Why?
|
| Prognosis | 1 | 2020 | 4488 | 0.090 |
Why?
|
| Neoplasms | 1 | 2022 | 2753 | 0.080 |
Why?
|
| Pregnancy | 3 | 2024 | 7092 | 0.070 |
Why?
|
| Risk Factors | 1 | 2020 | 9902 | 0.060 |
Why?
|
| Calibration | 1 | 2025 | 83 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 1 | 2023 | 27 | 0.060 |
Why?
|
| Models, Cardiovascular | 1 | 2025 | 170 | 0.060 |
Why?
|
| Ductus Arteriosus | 1 | 2024 | 64 | 0.060 |
Why?
|
| Cholesterol, HDL | 1 | 2024 | 347 | 0.050 |
Why?
|
| Angiography | 1 | 2023 | 214 | 0.050 |
Why?
|
| Replantation | 1 | 2023 | 54 | 0.050 |
Why?
|
| Athletes | 1 | 2023 | 59 | 0.050 |
Why?
|
| Arteries | 1 | 2023 | 219 | 0.050 |
Why?
|
| Triglycerides | 1 | 2024 | 560 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2025 | 607 | 0.050 |
Why?
|
| Cholesterol | 1 | 2024 | 521 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 458 | 0.050 |
Why?
|
| Systole | 1 | 2022 | 197 | 0.050 |
Why?
|
| Lipids | 1 | 2024 | 512 | 0.050 |
Why?
|
| Health Behavior | 1 | 2024 | 378 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2023 | 418 | 0.050 |
Why?
|
| Connecticut | 1 | 2019 | 20 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2024 | 901 | 0.040 |
Why?
|
| Fetus | 1 | 2021 | 579 | 0.040 |
Why?
|
| Registries | 1 | 2024 | 1367 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 2371 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2019 | 187 | 0.040 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2024 | 648 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2796 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4151 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5013 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 25640 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 3626 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2010 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3050 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6182 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2022 | 3307 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3229 | 0.030 |
Why?
|
| Hospitalization | 1 | 2019 | 1727 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 18785 | 0.020 |
Why?
|